Novo Nordisk
-
Wegovy Shows Promise in Treating Advanced Liver Disease, Study Finds
Clinical trials reveal Wegovy’s potential to treat metabolic dysfunction-associated steatohepatitis (MASH), reducing liver inflammation and fibrosis in patients.
Clinical trials reveal Wegovy’s potential to treat metabolic dysfunction-associated steatohepatitis (MASH), reducing liver inflammation and fibrosis in patients.